Mapp Biopharmaceutical, Inc. Contracts with Department of Health and Human Services
Relationship Overview
Total Contract Value: $515,780,180
Contract Count: 7
Average Contract Size: $73.7M
Sole Source Rate: 0%
Small Business Rate: 0%
Spending by Sector
- R&D: $515.8M (7 contracts)
Contracts
- PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES — $184.8M
- THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION. — $110.9M
- IGF::OT::IGF — $65.8M
- IGF::OT::IGF — $56.7M
- IGF::CL::IGF FOR OTHER FUNCTIONS ADVANCED DEVELOPMENT OF ZMAPP, AN EBOLA VIRUS CANDIDATE MEDICAL COUNTERMEASURE — $52.4M
- MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP — $28.9M
- DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE — $16.4M
Frequently Asked Questions
How many contracts does Mapp Biopharmaceutical, Inc. have with Department of Health and Human Services?
Mapp Biopharmaceutical, Inc. has 7 contracts with Department of Health and Human Services worth a combined $515.8M.
What is the average contract size between Mapp Biopharmaceutical, Inc. and Department of Health and Human Services?
The average contract size is $73.7M.
What percentage of Mapp Biopharmaceutical, Inc.'s contracts with Department of Health and Human Services are sole-source?
0% of the contracts are sole-source awards.